F T Cutts1, M J Ferrari2, L K Krause3, A J Tatem4, J F Mosser5. 1. Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. felicity.cutts@lshtm.ac.uk. 2. Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA, USA. 3. Vaccine Delivery, Global Development, The Bill & Melinda Gates Foundation, Seattle, WA, USA. 4. WorldPop, Department of Geography and Environmental Science, University of Southampton, Highfield, Southampton, SO17 1BJ, UK. 5. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, 98121, USA.
Abstract
BACKGROUND: Through a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimination. The fragility of these achievements has been shown, however, by the resurgence of measles since 2016. We describe trends in routine measles vaccine coverage at national and district level, SIA performance and demographic changes in the three regions with the highest measles burden. FINDINGS: WHO-UNICEF estimates of immunization coverage show that global coverage of the first dose of measles vaccine has stabilized at 85% from 2015 to 19. In 2000, 17 countries in the WHO African and Eastern Mediterranean regions had measles vaccine coverage below 50%, and although all increased coverage by 2019, at a median of 60%, it remained far below levels needed for elimination. Geospatial estimates show many low coverage districts across Africa and much of the Eastern Mediterranean and southeast Asian regions. A large proportion of children unvaccinated for MCV live in conflict-affected areas with remote rural areas and some urban areas also at risk. Countries with low RI coverage use SIAs frequently, yet the ideal timing and target age range for SIAs vary within countries, and the impact of SIAs has often been mitigated by delays or disruptions. SIAs have not been sufficient to achieve or sustain measles elimination in the countries with weakest routine systems. Demographic changes also affect measles transmission, and their variation between and within countries should be incorporated into strategic planning. CONCLUSIONS: Rebuilding services after the COVID-19 pandemic provides a need and an opportunity to increase community engagement in planning and monitoring services. A broader suite of interventions is needed beyond SIAs. Improved methods for tracking coverage at the individual and community level are needed together with enhanced surveillance. Decision-making needs to be decentralized to develop locally-driven, sustainable strategies for measles control and elimination.
BACKGROUND: Through a combination of strong routine immunization (RI), strategic supplemental immunization activities (SIA) and robust surveillance, numerous countries have been able to approach or achieve measles elimination. The fragility of these achievements has been shown, however, by the resurgence of measles since 2016. We describe trends in routine measles vaccine coverage at national and district level, SIA performance and demographic changes in the three regions with the highest measles burden. FINDINGS: WHO-UNICEF estimates of immunization coverage show that global coverage of the first dose of measles vaccine has stabilized at 85% from 2015 to 19. In 2000, 17 countries in the WHO African and Eastern Mediterranean regions had measles vaccine coverage below 50%, and although all increased coverage by 2019, at a median of 60%, it remained far below levels needed for elimination. Geospatial estimates show many low coverage districts across Africa and much of the Eastern Mediterranean and southeast Asian regions. A large proportion of children unvaccinated for MCV live in conflict-affected areas with remote rural areas and some urban areas also at risk. Countries with low RI coverage use SIAs frequently, yet the ideal timing and target age range for SIAs vary within countries, and the impact of SIAs has often been mitigated by delays or disruptions. SIAs have not been sufficient to achieve or sustain measles elimination in the countries with weakest routine systems. Demographic changes also affect measles transmission, and their variation between and within countries should be incorporated into strategic planning. CONCLUSIONS: Rebuilding services after the COVID-19 pandemic provides a need and an opportunity to increase community engagement in planning and monitoring services. A broader suite of interventions is needed beyond SIAs. Improved methods for tracking coverage at the individual and community level are needed together with enhanced surveillance. Decision-making needs to be decentralized to develop locally-driven, sustainable strategies for measles control and elimination.
Authors: Carlos Castillo-Solorzano; Christina Marsigli; M Carolina Danovaro-Holliday; Cuauhtémoc Ruiz-Matus; Gina Tambini; Jon Kim Andrus Journal: J Infect Dis Date: 2011-07 Impact factor: 5.226
Authors: D J Weiss; A Nelson; H S Gibson; W Temperley; S Peedell; A Lieber; M Hancher; E Poyart; S Belchior; N Fullman; B Mappin; U Dalrymple; J Rozier; T C D Lucas; R E Howes; L S Tusting; S Y Kang; E Cameron; D Bisanzio; K E Battle; S Bhatt; P W Gething Journal: Nature Date: 2018-01-10 Impact factor: 49.962
Authors: C Edson Utazi; Julia Thorley; Victor A Alegana; Matthew J Ferrari; Saki Takahashi; C Jessica E Metcalf; Justin Lessler; Felicity T Cutts; Andrew J Tatem Journal: Nat Commun Date: 2019-04-09 Impact factor: 14.919
Authors: Messeret E Shibeshi; Balcha G Masresha; Sheilagh B Smit; Robin J Biellik; Jennifer L Nicholson; Charles Muitherero; Nestor Shivute; Oladapo Walker; Katsande Reggis; James L Goodson Journal: Vaccine Date: 2014-02-13 Impact factor: 3.641
Authors: Zachary Wagner; Sam Heft-Neal; Paul H Wise; Robert E Black; Marshall Burke; Ties Boerma; Zulfiqar A Bhutta; Eran Bendavid Journal: Lancet Glob Health Date: 2019-10-24 Impact factor: 26.763
Authors: F T Cutts; E Dansereau; M J Ferrari; M Hanson; K A McCarthy; C J E Metcalf; S Takahashi; A J Tatem; N Thakkar; S Truelove; E Utazi; A Wesolowski; A K Winter Journal: Vaccine Date: 2019-11-29 Impact factor: 3.641
Authors: Catherine Decouttere; Stany Banzimana; Pål Davidsen; Carla Van Riet; Corinne Vandermeulen; Elizabeth Mason; Mohammad S Jalali; Nico Vandaele Journal: Bull World Health Organ Date: 2021-09-28 Impact factor: 9.408
Authors: Alvin Pumelele Ndondo; Brian Eley; Jo Madeleine Wilmshurst; Angelina Kakooza-Mwesige; Maria Pia Giannoccaro; Hugh J Willison; Pedro M Rodríguez Cruz; Jeannine M Heckmann; Kathleen Bateman; Angela Vincent Journal: Front Immunol Date: 2022-03-09 Impact factor: 7.561
Authors: Katy Am Gaythorpe; Kaja Abbas; John Huber; Andromachi Karachaliou; Niket Thakkar; Matthew Ferrari; Michael L Jackson; Kevin McCarthy; T Alex Perkins; Caroline Trotter; Mark Jit; Kim Woodruff; Xiang Li; Susy Echeverria-Londono Journal: Elife Date: 2021-06-24 Impact factor: 8.140